The market was primarily driven by several key factors, including increased R&D spending in the pharmaceutical industry, advancements in drug delivery device technology, and the rising prevalence of chronic diseases. For instance, in 2022, SHL Medical introduced an innovative approach called Needle Isolation Technology (NIT) to address issues with cartridge-based injection devices. This technology featured a pre-installed needle concealed within the device, eliminating the need for manual needle attachment. With this technology, users can simply remove the cap to insert the needle before injection, facilitating automatic priming of the injector and opening of the fluid route. Thus, the introduction of novel drug delivery systems along with advancements are expected to fuel the growth of the market.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The global pharmaceutical cartridges market was valued at USD 2 billion in 2023 and will reach USD 3.8 billion by 2032, driven by the increasing demand for pharmaceutical drug delivery devices.
The dual chamber cartridges type segment held 64.3% of the market share in 2023 and will expand rapidly till 2032, owing to its benefits in pharmaceutical administration, including compatibility with various injection devices.
North America pharmaceutical cartridges market held a decent share in 2023 and will reach USD 1.3 billion by 2032, driven by the increasing demand for drugs and precise delivery systems.
AptarGroup, Inc., Baxter International Inc., Dätwyler Holding Inc., Gerresheimer AG, Merck KGaA, Nipro Corporation, Schott Group, Shandong Medicinal Glass Co., Ltd., Stevanato Group, and Transcoject GmbH among others.